Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

Back to Top

President's Message

IPA Bulletin: VOLUME 38, NO. 1 • MARCH 2021

William Reichman, IPA President

Dear Colleagues,

As I am writing this many parts of the world are still struggling to contain the pandemic with several more transmissible and lethal COVID-19 variants potentially emerging. It remains unclear to what extent these variants will respond to available and pending vaccines and how this will impact the severity of the pandemic in the coming months. As a result of this uncertainty, and the ongoing restrictions that the pandemic continues to place on international travel, we have decided that the 2021 IPA Congress will once again be held virtually. We aspire to create a novel and creative program comprised of several educational offerings that enhance interest, participation, and satisfaction. While a firm date has not yet been established for the virtual 2021 IPA Congress, I urge you to stay tuned for further information. The originally planned IPA Congress scheduled for this coming September in Kyoto, Japan will instead be held as a live joint IPA/Japanese Psychiatric Society Regional Meeting. There may also be virtual programming available in this meeting for access by IPA members.

Despite the very challenging impact of the pandemic on our IPA activities, we continue to be very busy crafting and delivering new programs and services to best meet your needs as dedicated members. On 4 February, all members received a new Membership Survey. It is very important that you take a few minutes to provide your feedback. Your candid survey responses will be used to review, not only your overall satisfaction with current IPA membership benefits, but also to identify how we can strengthen and diversify our offerings to our members.

One particular initiative that is being launched by our Membership Committee this year is the IPA Young Researchers Network (YRN). This activity will provide opportunities for early-career clinicians and researchers to meet and network with international colleagues.

Three early-career IPA leaders have already begun planning the network’s activities for 2021:

  • Sascha Bolt, The Netherlands
  • Tomas León, Chile
  • Calvin Swords, Ireland

The YRN will focus on addressing four main needs of early-career professionals:

  1. Peer collaboration
  2. Organization & leadership experience
  3. Research Experience
  4. Clinical experience

With this in mind, the YRN is in the process of developing a website as a platform for sharing research opportunities and organizing meetings for research collaboration, scientific writing skill development, methodological workshops, and "Ask the Expert" sessions.

More information on the group can be found on the IPA website. I encourage early-career members to watch for updates on the web page and in future IPA Bulletins and Briefs for more information as it becomes available.

In the meantime, I wish you, your colleagues, friends and families a much better 2021. We are very grateful for all you do for your patients around the world and for your ongoing support of IPA.

With Kindest Regards.
William Reichman


Acadia Pharmaceuticals Avanir Pharmaceuticals Cambridge University Press Otsuka Pharmaceuticals